Sublingual misoprostol vs oxytocin in women not exposed to oxytocin during labor
- August 3rd, 2015
- Staff Publication
- Postpartum Hemorrhage
- Winikoff, Beverly, Blum, Jennifer, Dabash, Rasha, Raghavan, Sheila, Durocher, Jill, Darwish, E., Ngoc, N.T.N.,León, W., Medhat, I., Chi, H.T.K., Barrera, G.
This article describes the results of a clinical trial seeking to evaluate the use of misoprostol compared to standard oxytocics for treatment of postpartum hemorrhage in women who were not previously exposed to oxytocin during labor. The results demonstrate that misoprostol may be a suitable first-line treatment alternative for this indication particularly in settings in which use of oxytocin is not feasible.
Access the abstract.